These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 18098321

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The effect of lifestyle changes in non-alcoholic fatty liver disease.
    Centis E, Marzocchi R, Di Domizio S, Ciaravella MF, Marchesini G.
    Dig Dis; 2010; 28(1):267-73. PubMed ID: 20460922
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Metformin use in children with nonalcoholic fatty liver disease: an open-label, 24-month, observational pilot study.
    Nobili V, Manco M, Ciampalini P, Alisi A, Devito R, Bugianesi E, Marcellini M, Marchesini G.
    Clin Ther; 2008 Jun; 30(6):1168-76. PubMed ID: 18640473
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. High cardiorespiratory fitness is an independent predictor of the reduction in liver fat during a lifestyle intervention in non-alcoholic fatty liver disease.
    Kantartzis K, Thamer C, Peter A, Machann J, Schick F, Schraml C, Königsrainer A, Königsrainer I, Kröber S, Niess A, Fritsche A, Häring HU, Stefan N.
    Gut; 2009 Sep; 58(9):1281-8. PubMed ID: 19074179
    [Abstract] [Full Text] [Related]

  • 10. Nonalcoholic fatty liver disease: from clinical recognition to treatment.
    Sevastianos VA, Hadziyannis SJ.
    Expert Rev Gastroenterol Hepatol; 2008 Feb; 2(1):59-79. PubMed ID: 19072371
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Non-alcoholic fatty liver disease in children: a new complication of obesity].
    Bocca G, Stolk RP, Scheenstra R, Sauer PJ.
    Ned Tijdschr Geneeskd; 2008 Nov 08; 152(45):2443-7. PubMed ID: 19051794
    [Abstract] [Full Text] [Related]

  • 13. Lifestyle intervention and antioxidant therapy in children with nonalcoholic fatty liver disease: a randomized, controlled trial.
    Nobili V, Manco M, Devito R, Di Ciommo V, Comparcola D, Sartorelli MR, Piemonte F, Marcellini M, Angulo P.
    Hepatology; 2008 Jul 08; 48(1):119-28. PubMed ID: 18537181
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Prevention and treatment of nonalcoholic fatty liver disease.
    Targher G, Bellis A, Fornengo P, Ciaravella F, Pichiri I, Cavallo Perin P, Trimarco B, Marchesini G.
    Dig Liver Dis; 2010 May 08; 42(5):331-40. PubMed ID: 20207207
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Nonalcoholic fatty liver disease: the potential role of nutritional management.
    Leclercq IA, Horsmans Y.
    Curr Opin Clin Nutr Metab Care; 2008 Nov 08; 11(6):766-73. PubMed ID: 18827582
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.